- Home
- CDIO vs XPON Comparison
CDIO vs XPON Comparison
Compare CDIO & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDIO | XPON |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 6.2M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | CDIO | XPON |
|---|---|---|
| Price | $2.88 | $1.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 31.0K | ★ 2.2M |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,782.00 | ★ $9,417,947.00 |
| Revenue This Year | $1,434.82 | $61.26 |
| Revenue Next Year | $4,661.91 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 109.37 |
| 52 Week Low | $2.42 | $0.60 |
| 52 Week High | $53.10 | $5.50 |
Technical Indicators
Market Signals| Indicator | CDIO | XPON |
|---|---|---|
| Relative Strength Index (RSI) | 39.14 | 47.85 |
| Support Level | $2.84 | $1.04 |
| Resistance Level | $3.22 | $1.18 |
| Average True Range (ATR) | 0.34 | 0.12 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 31.12 | 29.51 |
Price Performance
Historical ComparisonAbout CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.